GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » REMSleep Holdings Inc (OTCPK:RMSL) » Definitions » Debt-to-EBITDA

REMSleep Holdings (REMSleep Holdings) Debt-to-EBITDA : -0.04 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is REMSleep Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

REMSleep Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.13 Mil. REMSleep Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.04 Mil. REMSleep Holdings's annualized EBITDA for the quarter that ended in Dec. 2023 was $-4.08 Mil. REMSleep Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for REMSleep Holdings's Debt-to-EBITDA or its related term are showing as below:

RMSL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.8   Med: -0.31   Max: -0.09
Current: -0.11

During the past 13 years, the highest Debt-to-EBITDA Ratio of REMSleep Holdings was -0.09. The lowest was -0.80. And the median was -0.31.

RMSL's Debt-to-EBITDA is ranked worse than
100% of 430 companies
in the Medical Devices & Instruments industry
Industry Median: 1.245 vs RMSL: -0.11

REMSleep Holdings Debt-to-EBITDA Historical Data

The historical data trend for REMSleep Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

REMSleep Holdings Debt-to-EBITDA Chart

REMSleep Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 -0.54 -0.15 -0.38 -0.11

REMSleep Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -0.41 -0.29 -0.20 -0.04

Competitive Comparison of REMSleep Holdings's Debt-to-EBITDA

For the Medical Devices subindustry, REMSleep Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


REMSleep Holdings's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, REMSleep Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where REMSleep Holdings's Debt-to-EBITDA falls into.



REMSleep Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

REMSleep Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.134 + 0.044) / -1.669
=-0.11

REMSleep Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.134 + 0.044) / -4.08
=-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


REMSleep Holdings  (OTCPK:RMSL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


REMSleep Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of REMSleep Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


REMSleep Holdings (REMSleep Holdings) Business Description

Traded in Other Exchanges
N/A
Address
14175 ICOT Blvd, Suite 300, Clearwater, FL, USA, 33760
REMSleep Holdings Inc is focused on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. The company offers the product DeltaWave which is specifically designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Geographically, the business activity of the group functions through the region of the United States.
Executives
Russell Finlay Bird 10 percent owner, officer: President 722 50TH STREET, DES MOINES IA 50312
Tom J Wood director, officer: CEO 1170 CHERRYWOOD RD, WAYCROSS GA 31503
Thomas Brookes director, officer: VP & MD OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN 5G2
Matthew Sullivan director, officer: ASST. VP OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN5G2
David M Barnes officer: Chief Financial Officer 6800 JERICHO TURNPIKE, SUITE 208E, SYOSSET NY 11791
Walter Leslie Thistle director, other: Chairman of the Board 17 COLLINGWOOD CRESCENT, MOUNT PEARL A4 A1N5C6
Kat Exploration Inc. 10 percent owner 1149 TOPSAIL ROAD, MOUNT PEARL A4 A1N5G2
Ken Stead director, 10 percent owner, officer: CEO and President 15 BLADE CRESCENT, MOUNT PEARL A4 A1N 5L1
Ronald Davis officer: PRESIDENT 4412 8TH STREET SW, VERO BEACH FL 32968

REMSleep Holdings (REMSleep Holdings) Headlines

From GuruFocus

RemSleep Holdings Provides a Corporate Update on Testing

By Value_Insider Value_Insider 11-08-2022

REMSleep 510K Submission

By Marketwired Marketwired 10-28-2021

REMSleep Holdings -- Time Line Update

By Marketwired Marketwired 11-19-2020

RemSleep Holdings Inc. Issues Letter to Shareholders

By Stock market mentor Stock market mentor 01-06-2023

REMSleep 510K

By GlobeNewswire GlobeNewswire 06-02-2021

REMSleep 510K Submission

By Marketwired Marketwired 07-15-2021

REMSleep 510K

By Marketwired Marketwired 06-02-2021

REMSleep Patent Application

By GlobeNewswire GlobeNewswire 11-20-2020